We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REAL icon
576
The RealReal
REAL
$1.41B
$368K 0.03%
+68,279
New +$518K
PLMR icon
577
Palomar
PLMR
$3.79B
$366K 0.03%
2,671
-3,145
-54% -$373K
GAMB
578
DELISTED
Gambling.com
GAMB
$365K 0.03%
+28,903
New +$406K
FSBC icon
579
Five Star Bancorp
FSBC
$1.01B
$363K 0.03%
13,048
+2,999
+30% +$89.3K
IBEX icon
580
IBEX
IBEX
$489M
$363K 0.03%
+14,890
New +$357K
ICL icon
581
ICL Group
ICL
$6.58B
$358K 0.03%
62,853
+5,920
+10% +$34.8K
RIGL icon
582
Rigel Pharmaceuticals
RIGL
$723M
$356K 0.03%
19,815
-14
-0.1% -$284
APP icon
583
Applovin
APP
$134B
$356K 0.03%
1,344
-12,660
-90% -$4.36M
CGNT icon
584
Cognyte Software
CGNT
$655M
$355K 0.03%
+45,525
New +$415K
GFS icon
585
GlobalFoundries
GFS
$25.8B
$350K 0.02%
+9,476
New +$383K
TREE icon
586
LendingTree
TREE
$551M
$349K 0.02%
+6,951
New +$310K
FSUN
587
FirstSun Capital Bancorp
FSUN
$1.93B
$347K 0.02%
+9,588
New +$382K
KLIC icon
588
Kulicke & Soffa
KLIC
$4.34B
$341K 0.02%
+10,328
New +$424K
BFC icon
589
Bank First Corp
BFC
$1.68B
$340K 0.02%
3,375
MCBS icon
590
MetroCity Bankshares
MCBS
$1.02B
$340K 0.02%
12,331
+2,290
+23% +$68.7K
FNKO icon
591
Funko
FNKO
$346M
$339K 0.02%
49,426
-2
-0% -$23
MATV icon
592
Mativ Holdings
MATV
$479M
$338K 0.02%
+54,279
New +$443K
ETON icon
593
Eton Pharmaceutcials
ETON
$1.32B
$334K 0.02%
+25,755
New +$389K
MIR icon
594
Mirion Technologies
MIR
$3.56B
$333K 0.02%
+22,969
New +$361K
QURE icon
595
uniQure
QURE
$2.75B
$329K 0.02%
31,047
-51
-0.2% -$715
NATL icon
596
NCR Atleos
NATL
$3.51B
$327K 0.02%
12,406
-34,471
-74% -$1.03M
ZEUS
597
DELISTED
Olympic Steel
ZEUS
$324K 0.02%
+10,283
New +$346K
RL icon
598
Ralph Lauren
RL
$22.4B
$323K 0.02%
1,463
-19,103
-93% -$4.73M
CNH
599
CNH Industrial
CNH
$13.3B
$321K 0.02%
+26,102
New +$327K
ASTE icon
600
Astec Industries
ASTE
$1.17B
$319K 0.02%
9,263
-13,091
-59% -$450K

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.